Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
23.50
-0.47 (-1.96%)
At close: Oct 22, 2025, 4:00 PM EDT
23.50
0.00 (0.00%)
After-hours: Oct 22, 2025, 4:00 PM EDT
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $719.31 million as of October 22, 2025. Its market cap has increased by 13.65% in one year.
Market Cap
719.31M
Enterprise Value
-50.16M
1-Year Change
13.65%
Ranking
Category
Stock Price
$23.50
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $719.31M, an increase of 359.62%. That is a compound annual growth rate of 18.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 733.70M | 29.88% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.51B |
| Johnson & Johnson | 465.29B |
| AbbVie | 407.70B |
| UnitedHealth Group | 326.77B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 223.47B |